Colloidally Stabilized DSPE-PEG-Glucose/Calcium Phosphate Hybrid Nanocomposites for Enhanced Photodynamic Cancer Therapy via Complementary Mitochondrial Ca2+ Overload and Autophagy Inhibition.

Abstract

Autophagy inhibition could hinder the underlying protective mechanisms in the course of tumor treatment. The advances in autophagy inhibition have driven focus on the functionalized nanoplatforms by combining the current treatment paradigms with complementary autophagy inhibition for enhanced efficacy. Furthermore, Ca2+ overload is also a promising adjuvant target for the tumor treatment by augmenting mitochondrial damage. In this view, complementary mitochondrial Ca2+ overload and autophagy inhibition were first demonstrated as a novel strategy suitable for homing in on the shortage of photodynamic therapy (PDT). We constructed biodegradable tumor-targeted inorganic/organic hybrid nanocomposites (DPGC/OI) synchronously encapsulating IR780 and Obatoclax by biomineralization of the nanofilm method, which consists of pH-triggered calcium phosphate (CP), long circulation phospholipid block copolymers 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE)-poly(ethylene glycol) (PEG)2000-glucose (DPG). In the presence of the hydrophilic PEG chain and glucose transporter 1 (Glut-1) ligands, DPGC would become an effectively tumor-oriented nanoplatform. Subsequently, IR780 as an outstanding photosensitizer could produce increased amounts of toxic reactive oxygen species (ROS) after laser irradiation. Calcium phosphate (CP) as the Ca2+ nanogenerator could generate Ca2+ at low pH to induce mitochondrial Ca2+ overload. The dysfunction of mitochondria could enhance increased amounts of ROS. Based on the premise that autophagy would degrade dysfunctional organelles to sustain metabolism and homeostasis, which might participate in resistance to PDT, Obatoclax as an autophagy inhibitor would hinder the protective mechanism from cancer cells with negligible toxicity. Such an enhanced PDT via mitochondrial Ca2+ overload and autophagy inhibition could be realized by DPGC/OI.

• Authors: Xuan Wang, Yunhao Li, Xiongwei Deng, Fan Jia, Xinyue Cui, Jianqing Lu, Zian Pan, Yan Wu
• Journal: ACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 13 Issue 33 Pg. 39112-39125 (Aug 25 2021) ISSN: 1944-8252 [Electronic] United States
• PMID: 34384220 (Publication Type: Journal Article)

Chemical References

• 2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dimethyl-1-propylindolium
• Calcium Phosphates
• Indoles
• Phosphatidylethanolamines
• Phospholipids
• Photosensitizing Agents
• Pyrroles
• Reactive Oxygen Species
• polyethylene glycol-distearoylphosphatidylethanolamine
• Polyethylene Glycols
• Glucose
• obatoclax

Topics

• Animals
• Autophagy (drug effects)
• Biological Transport
• Biomedical Enhancement
• Calcium Phosphates (chemistry)
• Female
• Glucose (chemistry)
• Humans
• Indoles (chemistry, metabolism, pharmacology)
• Mice, Inbred BALB C
• Mitochondria (metabolism, ultrastructure)
• Nanocomposites (chemistry)
• Neoplasms (diagnostic imaging, therapy)
• Phosphatidylethanolamines (chemistry)
• Phospholipids (chemistry)
• Photochemotherapy
• Photosensitizing Agents (chemistry, pharmacology)
• Polyethylene Glycols (chemistry)
• Pyrroles (chemistry, metabolism)
• Reactive Oxygen Species (metabolism)
• Signal Transduction
• Surface Properties
• Tissue Distribution
• Mice